Company Filing History:
Years Active: 2010
Title: Heike Herbert: Innovator in Insulin Preparation
Introduction
Heike Herbert is a notable inventor based in Gernsheim, Germany. She has made significant contributions to the field of biochemistry, particularly in the preparation of insulin and its derivatives. Her innovative work has led to advancements in the pharmaceutical industry, enhancing the methods used for insulin production.
Latest Patents
Heike Herbert holds a patent for a process for the preparation of insulin or an insulin derivative in the presence of oxygen. This invention involves a method for preparing insulin with correctly linked cysteine bridges from a precursor. The process includes a folding procedure using cysteine or cysteine hydrochloride and a chaotropic auxiliary compound. The resulting insulin is obtained through enzymic cleavage by trypsin or a trypsin-like enzyme, and it may also involve carboxypeptidase B, followed by purification on an adsorber resin. This innovative method is conducted at varied pH and temperature ranges, showcasing her expertise in biochemical processes. She has 1 patent to her name.
Career Highlights
Heike Herbert is currently associated with Sanofi-Aventis Deutschland GmbH, a leading global pharmaceutical company. Her role at Sanofi highlights her commitment to advancing medical science and improving patient care through innovative solutions.
Collaborations
Throughout her career, Heike has collaborated with esteemed colleagues, including Franz-Josef Rubroeder and Reinhold Keller. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of biochemistry.
Conclusion
Heike Herbert's contributions to insulin preparation represent a significant advancement in pharmaceutical science. Her innovative processes and collaborations continue to impact the industry positively.